PerkinElmer (NYSE:PKI) announced today that it received FDA emergency use authorization (EUA) for its EuroImmun subsidiary’s COVID-19 serology test. The Waltham, Mass.-based company’s Anti-SARS-CoV-2 ELISA serology test for detecting the IgG antibody in COVID-19 patients is now available for immediate use in clinical laboratories. PerkinElmer and EuroImmun designed the ELISA test to aid in identifying individuals […]
euroimmun
Quest Diagnostics launches patient-ordered COVID-19 antibody test
Quest Diagnostics (NYSE:DGX) announced today that consumers can now order a COVID-19 antibody test it launched last week directly from the company, without visiting a doctor’s office. The Secaucus, N.J.-based testing giant said consumers can purchase the antibody test service online for $119 through its QuestDirect business. They will be prompted to schedule an appointment for […]
PerkinElmer closes $1.3B Euroimmun buy
PerkinElmer (NYSE:PKI) has closed its $1.3 billion deal to buy Euroimmun Medical Laboratory Diagnostics, the scientific instrument-maker reported today. The acquisition, first announced in June, involves Euroimmun’s 2,400 employees and autoimmune testing solutions. The move helps to expand PerkinElmer’s footprint in autoimmune and allergy diagnostic markets. Get the full story at our sister site, Drug Delivery Business News.
PerkinElmer to buy Euroimmun in $1.3B deal
PerkinElmer (NYSE:PKI) inked a deal today to acquire Euroimmun Medical Laboratory Diagnostics for $1.3 billion in cash. The move is an effort to expand into autoimmune and allergy diagnostic markets, according to the scientific instruments-maker. Germany-based Euroimmun has 2,400 employees and is expected to bring in $310 million in revenue this year. Get the full […]
